Teruflex Blood Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) For Collection Of 450ml Of Blood Solution
Product Images NDC 53877-108
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Teruflex Blood Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) For Collection Of 450ml Of Blood (NDC 53877-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Terumo Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig. 3a, Fig. 3b (Teruflex 02)
Figure (Teruflex 03)
Figure (Teruflex 04)
Figure (Teruflex 05)
Figure (Teruflex 06)
Figure (Teruflex 07)
Principal Display Panel (63 mL Bag Blister Pack Case Label)
This is a description of the Teruflex blood bag system by Terumo Corporation, designed for use with anticoagulant citrate phosphate dextrose adenine solution (CPDA-1) for the collection of 450mL of blood. The system includes a primary bag with specific measurements of citric acid, sodium citrate, sodium phosphate, dextrose, and adenine. It is sterile, non-pyrogenic, and requires a 16G donor needle for use. The recommended storage is at room temperature to ensure proper functionality. The system provides instructions for use and storage after opening, including details on shelf life and moisture protection. Manufactured by Terumo Corporation in Tokyo, Japan.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.